Steven M. Fruchtman

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Newtown, PA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Mark Guerin, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Steven M. Fruchtman

Form 4 holding PRESIDENT, CHIEF EXECUTIVE OFF, Director

Onconova Therapeutics, Inc.

Security class
Common Stock
Shares / value
74,792
Estimated value
$67,313
Report date
14 Mar 2024
Price
$0.9000
Ownership
Direct
Form 4 holding PRESIDENT, CHIEF EXECUTIVE OFF, Director

Onconova Therapeutics, Inc.

Security class
Restricted Stock Units
Shares / value
46,222
Estimated value
$30,969
Report date
13 Mar 2024
Price
$0.6700
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Steven M. Fruchtman

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .